DEPO-TESTOSTERONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Depo-testosterone, and what generic alternatives are available?
Depo-testosterone is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in DEPO-TESTOSTERONE is testosterone cypionate. There are sixty-nine drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the testosterone cypionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Depo-testosterone
A generic version of DEPO-TESTOSTERONE was approved as testosterone cypionate by WILSHIRE PHARMS INC on April 24th, 2019.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEPO-TESTOSTERONE?
- What are the global sales for DEPO-TESTOSTERONE?
- What is Average Wholesale Price for DEPO-TESTOSTERONE?
Summary for DEPO-TESTOSTERONE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 44 |
Clinical Trials: | 1,045 |
Patent Applications: | 3,063 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for DEPO-TESTOSTERONE |
DailyMed Link: | DEPO-TESTOSTERONE at DailyMed |
![DEPO-TESTOSTERONE drug patent expirations Drug patent expirations by year for DEPO-TESTOSTERONE](/p/graph/s/t/DEPO-TESTOSTERONE-patent-expirations.png)
![Drug Prices for DEPO-TESTOSTERONE](/p/graph/drug-price/DEPO-TESTOSTERONE.png)
Recent Clinical Trials for DEPO-TESTOSTERONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Morten Hostrup, PhD | N/A |
VA Office of Research and Development | Early Phase 1 |
Jonsson Comprehensive Cancer Center | Phase 2 |
Pharmacology for DEPO-TESTOSTERONE
Drug Class | Androgen |
Mechanism of Action | Androgen Receptor Agonists |
US Patents and Regulatory Information for DEPO-TESTOSTERONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | DEPO-TESTOSTERONE | testosterone cypionate | INJECTABLE;INJECTION | 085635-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer | DEPO-TESTOSTERONE | testosterone cypionate | INJECTABLE;INJECTION | 085635-002 | Approved Prior to Jan 1, 1982 | AO | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Pfizer | DEPO-TESTOSTERONE | testosterone cypionate | INJECTABLE;INJECTION | 085635-003 | Approved Prior to Jan 1, 1982 | AO | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |